A review on upregulation of glucokinase expression by selected plants and their phytoconstituents

Divya Jyothi Palati; Divya Bhargavi Pulukuri; Prudvi Raj Pulla; K. M. Muhasina; Duraiswamy Basavan

doi:10.53730/ijhs.v6nS3.8631

Authors

Divya Jyothi Palati Department of Pharmacognosy, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty-643001, The Nilgiris, Tamil Nadu, India
Divya Bhargavi Pulukuri Department of Pharmacognosy, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty-643001, The Nilgiris, Tamil Nadu, India
Prudvi Raj Pulla Department of pharmaceutical chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty-643001, The Nilgiris, Tamil Nadu, India
Muhasina K. M. Department of Pharmacognosy, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty-643001, The Nilgiris, Tamil Nadu, India
Duraiswamy Basavan
bdurais@jssuni.edu.in
Department of Pharmacognosy, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty-643001, The Nilgiris, Tamil Nadu, India

Keywords:

glucokinase, diabetes, glucose homeostasis, medicinal plants, phytochemicals

Abstract

Glucokinase is, an allosteric enzyme involved in glycolysis, is rapidly regulated in the liver through glucokinase regulatory protein and remains essential for blood glucose homeostasis. The present review provides brief information about the effects of a few selected plants and phytochemicals on human glucokinase activation and gene modulation. A thorough and relevant literature search from several scientific databases, comprising Google Scholar, Web of Science, Scopus and PubMed, was carried out. We highlighted the seven plants (Acorus tatariowii Schott, Allium hirtifolium Boiss, Apache red maize, Mulberry species, Pterocarpus marsupium, Sapium ellepticum, Mangifera indica) and their phytoconstituents ( Tatanans A-C, alliogenin , gitogenin , kaempferol , quercetin and shallomin,1-deoxynojirimycin,cyanidin-3-rutinoside,resveratrol,cyanidin-3-glucoside,oxyresveratrol, lupeol, alpha-tocopherol, uteolin-7-glucoside, amentoflavone, and Mangiferin) on human glucokinase enzyme activation and gene modulation. This review concluded that investigation of glucokinase activators of plant origin is the major research focus in the management of type 2 diabetes.

Downloads

Download data is not yet available.

References

IDF Diabetes Atlas 10th edition 2021. https://www.diabetesatlas.org/en/.

Tahrani, A. A., Barnett, A. H., & Bailey, C. J. (2016). Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus. Nature Reviews Endocrinology, 12(10), 566-592.

Laurian, R., Dementhon, K., Doumèche, B., Soulard, A., Noel, T., Lemaire, M., & Cotton, P. (2019). Hexokinase and glucokinases are essential for fitness and virulence in the pathogenic yeast Candida albicans. Frontiers in microbiology, 10, 327.

Matschinsky, F. M., Magnuson, M. A., Zelent, D., Jetton, T. L., Doliba, N., Han, Y., ... & Grimsby, J. (2006). The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes, 55(1), 1-12.3

Minassian, C., Tarpin, S., & Mithieux, G. (1998). Role of glucose-6 phosphatase, glucokinase, and glucose-6 phosphate in liver insulin resistance and its correction by metformin. Biochemical pharmacology, 55(8), 1213-1219.

Agius, L. (2009). Targeting hepatic glucokinase in type 2 diabetes: weighing the benefits and risks. Diabetes, 58(1), 18-20.

Simons, P. I., Simons, N., Stehouwer, C. D., Schalkwijk, C. G., Schaper, N. C., & Brouwers, M. C. (2018). Association of common gene variants in glucokinase regulatory protein with cardiorenal disease: A systematic review and meta-analysis. PloS one, 13(10), e0206174.

Dunn-Meynell, A. A., Routh, V. H., Kang, L., Gaspers, L., & Levin, B. E. (2002). Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes, 51(7), 2056-2065.

Jetton, T. L., Liang, Y., Pettepher, C. C., Zimmerman, E. C., Cox, F. G., Horvath, K., & Magnuson, M. A. (1994). Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. Journal of Biological Chemistry, 269(5), 3641-3654.

Murphy, R., Tura, A., Clark, P. M., Holst, J. J., Mari, A., & Hattersley, A. T. (2009). Glucokinase, the pancreatic glucose sensor, is not the gut glucose sensor. Diabetologia, 52(1), 154-159.

Zelent, D., Golson, M. L., Koeberlein, B., Quintens, R., Van Lommel, L., Buettger, C. & Matschinsky, F. M. (2006). A glucose sensor role for glucokinase in anterior pituitary cells. Diabetes, 55(7), 1923-1929.

Froguel, P., Zouali, H., Vionnet, N., Velho, G., Vaxillaire, M., Sun, F., & Cohen, D. (1993). Familial hyperglycemia due to mutations in glucokinase--definition of a subtype of diabetes mellitus. New England Journal of Medicine, 328(10), 697-702.

De León DD, Stanley CA, 2008.Permanent Neonatal Diabetes Mellitus. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from:

https://www.ncbi.nlm.nih.gov/books/NBK1447/

Byrne, M. M., Sturis, J., Clement, K., Vionnet, N., Pueyo, M. E., Stoffel, M., & Bell, G. I. (1994). Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. The Journal of clinical investigation, 93(3), 1120-1130.

Glaser, B., Kesavan, P., Heyman, M., Davis, E., Cuesta, A., Buchs, A., ... & Herold, K. C. (1998). Familial hyperinsulinism caused by an activating glucokinase mutation. New England Journal of Medicine, 338(4), 226-230.

Beer, N. L., Tribble, N. D., McCulloch, L. J., Roos, C., Johnson, P. R., Orho-Melander, M., & Gloyn, A. L. (2009). The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Human molecular genetics, 18(21), 4081-4088.

Matschinsky, F. M., & Porte Jr, D. (2010). Glucokinase activators (GKAs) promise a new pharmacotherapy for diabetics. F1000 medicine reports, 2.

Bai, Y., Sun, Y., Xie, J., Li, B., Bai, Y., Zhang, D. & Zheng, X. (2020). The asarone-derived phenylpropanoids from the rhizome of Acorus calamus var. angustatus Besser. Phytochemistry, 170, 112212.

Ni, G., Shen, Z. F., Lu, Y., Wang, Y. H., Tang, Y. B., Chen, R. Y., ... & Yu, D. Q. (2011). Glucokinase-activating sesquinlignans from the rhizomes of Acorus tatarinowii Schott. The Journal of Organic Chemistry, 76(7), 2056-2061.

Ghodrati Azadi, H., Fathi, B., Kazemi Mehrjerdi, H., Maleki, M., Shaterzadeh, H., & Abyazi, M. (2011). Macroscopic evaluation of wound healing activity of the Persian shallot, Allium hirtifolium in rat. Iranian Journal of Veterinary Science and Technology, 3(1), 31-38.

Grewal, A. S., Arora, S., Sharma, N., & Singh, S. (2020). In silico docking studies of compounds from Persian shallot as allosteric glucokinase activators. Plant Arch, 20, 3768-3771.

Luna-Vital, D. A., Chatham, L., Juvik, J., Singh, V., Somavat, P., & De Mejia, E. G. (2019). Activating effects of phenolics from Apache Red Zea mays L. on free fatty acid receptor 1 and glucokinase evaluated with a dual culture system with epithelial, pancreatic, and liver cells. Journal of agricultural and food chemistry, 67(33), 9148-9159.

Dar, A., Faizi, S., Naqvi, S., Roome, T., Zikr-ur-Rehman, S., Ali, M., ... & Moin, S. T. (2005). Analgesic and antioxidant activity of mangiferin and its derivatives: the structure activity relationship. Biological and Pharmaceutical Bulletin, 28(4), 596-600.

Min, Q., Cai, X., Sun, W., Li, Z., Zhang, Q., Wan, L. S., ... & Chen, J. (2017). Identification of mangiferin as a potential glucokinase activator by structure-based virtual ligand screening. Scientific reports, 7(1), 1-9.

Tao, W., Deqin, Z., Yuhong, L., Hong, L., Zhanbiao, L., Chunfeng, Z., ... & Xiumei, G. (2010). Regulation effects on abnormal glucose and lipid metabolism of TZQ-F, a new kind of Traditional Chinese Medicine. Journal of ethnopharmacology, 128(3), 575-582.

Kuriyama, C., Kamiyama, O., Ikeda, K., Sanae, F., Kato, A., Adachi, I.,. & Asano, N. (2008). In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures. Bioorganic & medicinal chemistry, 16(15), 7330-7336.

Li, Y. G., Ji, D. F., Zhong, S., Lin, T. B., Lv, Z. Q., Hu, G. Y., & Wang, X. (2013). 1-deoxynojirimycin inhibits glucose absorption and accelerates glucose metabolism in streptozotocin-induced diabetic mice. Scientific Reports, 3(1), 1-12.

He, H., Yu, W. G., Yang, J. P., Ge, S., & Lu, Y. H. (2016). Multiple comparisons of glucokinase activation mechanisms of five mulberry bioactive ingredients in hepatocyte. Journal of agricultural and food chemistry, 64(12), 2475-2484.

Devgun, M., Nanda, A., & Ansari, S. (2009). Pterocarpus marsupium Roxb.-A comprehensive review. Pharmacognosy reviews, 3(6), 359.

Grover, J. K., Vats, V., & Yadav, S. (2002). Effect of feeding aqueous extract of Pterocarpus marsupium on glycogen content of tissues and the key enzymes of carbohydrate metabolism. Molecular and Cellular Biochemistry, 241(1), 53-59.

Lewis, W.H., 1986. The useful plants of west tropical Africa.

Ighodaro, O. M., Akinloye, O. A., Ugbaja, R. N., Omotainse, S. O., & Faokunla, O. (2016). FT-IR analysis of Sapium ellipticum (Hochst) pax ethanol leaf extract and its inhibitory effects on pancreatic α-amylase and intestinal α-glucosidase activities in vitro. Egyptian journal of basic and applied sciences, 3(4), 343-349.

Ighodaro, O. M., Akinloye, O. A., Ugbaja, R. N., & Omotainse, S. O. (2017). Sapium ellipticum (Hochst) Pax Ethanol Leaf Extract modulates glucokinase and glucose-6-phosphatase activities in streptozotocin induced diabetic rats. Asian Pacific journal of tropical biomedicine, 7(6), 544-548.

Grewal, A. S., Sharma, N., & Singh, S. (2019). Molecular docking investigation of compounds from sapium ellipticum (Hochst) pax as allosteric activators of human glucokinase. International Journal of Pharmaceutical Quality Assurance, 10(4), 588-596.